GB201203533D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB201203533D0
GB201203533D0 GBGB1203533.3A GB201203533A GB201203533D0 GB 201203533 D0 GB201203533 D0 GB 201203533D0 GB 201203533 A GB201203533 A GB 201203533A GB 201203533 D0 GB201203533 D0 GB 201203533D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1203533.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to GBGB1203533.3A priority Critical patent/GB201203533D0/en
Publication of GB201203533D0 publication Critical patent/GB201203533D0/en
Priority to JOP/2012/0232A priority patent/JO3115B1/en
Priority to MEP-2016-2A priority patent/ME02319B/en
Priority to EP12753164.8A priority patent/EP2748149B9/en
Priority to JP2014526537A priority patent/JP6022573B2/en
Priority to EA201490471A priority patent/EA024956B1/en
Priority to MX2014000783A priority patent/MX2014000783A/en
Priority to PT127531648T priority patent/PT2748149E/en
Priority to PL12753164T priority patent/PL2748149T3/en
Priority to ARP120103061A priority patent/AR087607A1/en
Priority to NZ620239A priority patent/NZ620239B2/en
Priority to CN201280040586.3A priority patent/CN103748079B/en
Priority to KR1020147007280A priority patent/KR101961851B1/en
Priority to BR112014003906-2A priority patent/BR112014003906B1/en
Priority to CA2846204A priority patent/CA2846204C/en
Priority to HUE12753164A priority patent/HUE026691T2/en
Priority to TW101130241A priority patent/TWI546289B/en
Priority to UY0001034280A priority patent/UY34280A/en
Priority to DK12753164.8T priority patent/DK2748149T5/en
Priority to SI201230375T priority patent/SI2748149T1/en
Priority to GEAP201213407A priority patent/GEP20156372B/en
Priority to ES12753164.8T priority patent/ES2559631T3/en
Priority to AP2014007512A priority patent/AP2014007512A0/en
Priority to RS20160010A priority patent/RS54515B9/en
Priority to MYPI2013004633A priority patent/MY180618A/en
Priority to PE2014000238A priority patent/PE20141208A1/en
Priority to US14/240,045 priority patent/US9290456B2/en
Priority to PCT/GB2012/000672 priority patent/WO2013027000A1/en
Priority to AU2012298335A priority patent/AU2012298335B2/en
Priority to US13/591,859 priority patent/US20130052281A1/en
Priority to IL230143A priority patent/IL230143A/en
Priority to ZA2014/00153A priority patent/ZA201400153B/en
Priority to CL2014000395A priority patent/CL2014000395A1/en
Priority to ECSP14013215 priority patent/ECSP14013215A/en
Priority to DO2014000036A priority patent/DOP2014000036A/en
Priority to TNP2014000077A priority patent/TN2014000077A1/en
Priority to CO14058009A priority patent/CO6910197A2/en
Priority to CR20140133A priority patent/CR20140133A/en
Priority to HK14107513.7A priority patent/HK1194072A1/en
Priority to HRP20151310TT priority patent/HRP20151310T2/en
Priority to CY20161100005T priority patent/CY1117105T1/en
Priority to SM201600023T priority patent/SMT201600023B/en
Priority to US15/014,336 priority patent/US9931340B2/en
Priority to US15/899,561 priority patent/US10463663B2/en
Priority to US16/580,095 priority patent/US11129828B2/en
Priority to US17/461,757 priority patent/US20220008416A1/en
Priority to ARP220102738A priority patent/AR127309A2/en
Ceased legal-status Critical Current

Links

GBGB1203533.3A 2011-08-22 2012-02-29 Novel compounds Ceased GB201203533D0 (en)

Priority Applications (47)

Application Number Priority Date Filing Date Title
GBGB1203533.3A GB201203533D0 (en) 2012-02-29 2012-02-29 Novel compounds
JOP/2012/0232A JO3115B1 (en) 2011-08-22 2012-08-15 Pyridazinone Compounds and Their Use as DAAO Inhibitors
MEP-2016-2A ME02319B (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
EP12753164.8A EP2748149B9 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
JP2014526537A JP6022573B2 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as DAAO inhibitors
EA201490471A EA024956B1 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
MX2014000783A MX2014000783A (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors.
PT127531648T PT2748149E (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
PL12753164T PL2748149T3 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
ARP120103061A AR087607A1 (en) 2011-08-22 2012-08-21 DERIVATIVES OF PIRIDAZINONA
NZ620239A NZ620239B2 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
CN201280040586.3A CN103748079B (en) 2011-08-22 2012-08-21 Pyridazinone mixture and the purposes as DAAO inhibitor thereof
KR1020147007280A KR101961851B1 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
BR112014003906-2A BR112014003906B1 (en) 2011-08-22 2012-08-21 Pyridazinone compounds as inhibitors of amino acid oxidase (daao) enzyme, their preparation process, pharmaceutical compositions and combinations comprising the same and intermediate compounds
CA2846204A CA2846204C (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
HUE12753164A HUE026691T2 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
TW101130241A TWI546289B (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
UY0001034280A UY34280A (en) 2011-08-22 2012-08-21 NEW COMPOUNDS THAT HAVE INHIBITING ACTIVITY AGAINST OXIDASE DAMINOACIDE.
DK12753164.8T DK2748149T5 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as DAAO inhibitors
SI201230375T SI2748149T1 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
GEAP201213407A GEP20156372B (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
ES12753164.8T ES2559631T3 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as DAAO inhibitors
AP2014007512A AP2014007512A0 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as DAAO inhibitors
RS20160010A RS54515B9 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
MYPI2013004633A MY180618A (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
PE2014000238A PE20141208A1 (en) 2011-08-22 2012-08-21 PYRIDAZINONE COMPOUNDS AND THEIR USE AS DAAO INHIBITORS
US14/240,045 US9290456B2 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as DAAO inhibitors
PCT/GB2012/000672 WO2013027000A1 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as daao inhibitors
AU2012298335A AU2012298335B2 (en) 2011-08-22 2012-08-21 Pyridazinone compounds and their use as DAAO inhibitors
US13/591,859 US20130052281A1 (en) 2011-08-22 2012-08-22 Novel compounds
IL230143A IL230143A (en) 2011-08-22 2013-12-24 Pyridazinone compounds and their use as daao inhibitors
ZA2014/00153A ZA201400153B (en) 2011-08-22 2014-01-08 Pyridazinone compounds and their use as daao inhibitors
CL2014000395A CL2014000395A1 (en) 2011-08-22 2014-02-17 Compounds derived from substituted pyridazinone; intermediate compound; pharmaceutical composition; pharmaceutical combination; and use in the treatment of schizophrenia, schizoaffective disorder, cognitive disorders or pain.
ECSP14013215 ECSP14013215A (en) 2011-08-22 2014-02-17 NEW COMPOUNDS
DO2014000036A DOP2014000036A (en) 2011-08-22 2014-02-19 PIRIDAZINONE COMPOUNDS AND ITS USE AS DAAO INHIBITORS
TNP2014000077A TN2014000077A1 (en) 2011-08-22 2014-02-21 Pyridazinone compounds and their use as daao inhibitors
CO14058009A CO6910197A2 (en) 2011-08-22 2014-03-18 Novel compounds
CR20140133A CR20140133A (en) 2011-08-22 2014-03-21 PIRIDAZINONA COMPOUNDS AND THEIR USES AS DAAO INHIBITORS
HK14107513.7A HK1194072A1 (en) 2011-08-22 2014-07-23 Pyridazinone compounds and their use as daao inhibitors daao(d-)
HRP20151310TT HRP20151310T2 (en) 2011-08-22 2015-12-01 Pyridazinone compounds and their use as daao inhibitors
CY20161100005T CY1117105T1 (en) 2011-08-22 2016-01-07 PYRIDAZINONIN COMPOUNDS AND USE AS DAAO SUSPENSIONS
SM201600023T SMT201600023B (en) 2011-08-22 2016-01-21 PYRIDAZINONIC COMPOUNDS AND THEIR USE AS INHIBITORS OF DAAO
US15/014,336 US9931340B2 (en) 2011-08-22 2016-02-03 Pyridazinone compounds and their use as DAAO inhibitors
US15/899,561 US10463663B2 (en) 2011-08-22 2018-02-20 Pyridazinone compounds and their use as DAAO inhibitors
US16/580,095 US11129828B2 (en) 2011-08-22 2019-09-24 Pyridazinone compounds and their use as DAAO inhibitors
US17/461,757 US20220008416A1 (en) 2011-08-22 2021-08-30 Pyridazinone compounds and their use as daao inhibitors
ARP220102738A AR127309A2 (en) 2011-08-22 2022-10-06 PYRDAZINONE DERIVATIVES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1203533.3A GB201203533D0 (en) 2012-02-29 2012-02-29 Novel compounds

Publications (1)

Publication Number Publication Date
GB201203533D0 true GB201203533D0 (en) 2012-04-11

Family

ID=45991926

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1203533.3A Ceased GB201203533D0 (en) 2011-08-22 2012-02-29 Novel compounds

Country Status (1)

Country Link
GB (1) GB201203533D0 (en)

Similar Documents

Publication Publication Date Title
HK1201819A1 (en) Novel compounds
GB201207406D0 (en) Novel compounds
HK1212985A1 (en) Novel compounds
EP2922550A4 (en) Novel compounds
HK1208826A1 (en) Novel compounds
GB201212871D0 (en) Novel compounds
EP2922547A4 (en) Novel compounds
GB201209986D0 (en) Novel compounds
IL280595A (en) Novel compounds
GB201222711D0 (en) Novel compounds
GB201207392D0 (en) Novel compounds
GB201209670D0 (en) Novel compounds
GB201212816D0 (en) Novel compounds
GB201222419D0 (en) Novel compounds
GB201222430D0 (en) Novel compounds
GB201222433D0 (en) Novel compounds
GB201222435D0 (en) Novel compounds
GB201222393D0 (en) Novel compounds
GB201219554D0 (en) Novel compounds
GB201219472D0 (en) Novel compounds
GB201217387D0 (en) Novel compounds
GB201216551D0 (en) Novel compounds
GB201216548D0 (en) Novel compounds
GB201213023D0 (en) Novel compounds
GB201211246D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)